564 related articles for article (PubMed ID: 15561811)
21. Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?
de Wit R; Aapro M; Blower PR
Cancer Chemother Pharmacol; 2005 Sep; 56(3):231-8. PubMed ID: 15838653
[TBL] [Abstract][Full Text] [Related]
22. Anti-emetic therapy in cancer chemotherapy: current status.
Herrstedt J; Dombernowsky P
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):143-50. PubMed ID: 17697032
[TBL] [Abstract][Full Text] [Related]
23. Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy.
Yarker YE; McTavish D
Drugs; 1994 Nov; 48(5):761-93. PubMed ID: 7530631
[TBL] [Abstract][Full Text] [Related]
24. Granisetron: new insights into its use for the treatment of chemotherapy-induced nausea and vomiting.
Tan M
Expert Opin Pharmacother; 2003 Sep; 4(9):1563-71. PubMed ID: 12943486
[TBL] [Abstract][Full Text] [Related]
25. [Modern aspects of antiemetic therapy].
Aleksandrović J; Dagović A; Jeremić B
Srp Arh Celok Lek; 1998; 126(7-8):295-303. PubMed ID: 9863398
[TBL] [Abstract][Full Text] [Related]
26. 5-HT3 receptor antagonists for prevention of late acute-onset emesis.
Constenla M
Ann Pharmacother; 2004 Oct; 38(10):1683-91. PubMed ID: 15316106
[TBL] [Abstract][Full Text] [Related]
27. [Croatian guideliness for prevention of chemotherapy induced nausea and vomiting].
Tomek R; Vrdoljak E; Vrbanec D; Nemet D; Matković V; Plestina S; Gugić D; Dintinjana RD; Bolanca A; Samarzija M; Petković M
Lijec Vjesn; 2009; 131(3-4):49-53. PubMed ID: 19514248
[TBL] [Abstract][Full Text] [Related]
28. [Clinical evaluation of granisetron (BRL43694) in nausea and vomiting induced by anticancer drugs--pediatrics].
Sawada T; Matsumura T; Mugishima H; Kaneko M; Ohira M; Sugimoto T; Onuma N; Sakurai M; Takeda T
Gan To Kagaku Ryoho; 1999 Aug; 26(9):1295-304. PubMed ID: 10478183
[TBL] [Abstract][Full Text] [Related]
29. [An outline of 5-HT3 receptor antagonists (2)--In clinical applications].
Tsukagoshi S; Ohta J; Taguchi T
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2276-81. PubMed ID: 8259839
[TBL] [Abstract][Full Text] [Related]
30. Clinical practice guidelines on antiemetics in oncology.
Aranda Aguilar E; Constenla Figueiras M; Cortes-Funes H; Diaz-Rubio García E; Gascon Vilaplana P; Guillém V; Martin-Algarra S
Expert Rev Anticancer Ther; 2005 Dec; 5(6):963-72. PubMed ID: 16336087
[TBL] [Abstract][Full Text] [Related]
31. Aprepitant: a novel antiemetic for chemotherapy-induced nausea and vomiting.
Massaro AM; Lenz KL
Ann Pharmacother; 2005 Jan; 39(1):77-85. PubMed ID: 15562136
[TBL] [Abstract][Full Text] [Related]
32. Aprepitant for the control of chemotherapy induced nausea and vomiting in adolescents.
Smith AR; Repka TL; Weigel BJ
Pediatr Blood Cancer; 2005 Nov; 45(6):857-60. PubMed ID: 15849684
[TBL] [Abstract][Full Text] [Related]
33. Management of radiation-induced nausea and vomiting.
Abdelsayed GG
Exp Hematol; 2007 Apr; 35(4 Suppl 1):34-6. PubMed ID: 17379085
[TBL] [Abstract][Full Text] [Related]
34. [Clinical evaluation of granisetron hydrochloride for nausea and vomiting induced by oral anticancer drugs].
Togo S; Kunisaki C; Moriwaki Y; Yamaguchi S; Ichikawa Y; Oki S; Shimada H; Takahashi M; Ike H; Fukushima T; Obi Y; Kubo A; Takahashi T; Hosoi H; Fukazawa S; Suda T; Yamazaki Y
Gan To Kagaku Ryoho; 2000 Jul; 27(7):1021-8. PubMed ID: 10925688
[TBL] [Abstract][Full Text] [Related]
35. [Clinical evaluation of 2-mg granisetron tablet for nausea and vomiting induced by anticancer drugs including cisplatin].
Yoshiya N; Kodama S; Aoki Y; Takahashi T; Honma S; Endo M; Tokunaga A; Takeuchi Y; Hanaoka J; Maruhashi T; Oshima T; Tanaka K; Furue H
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1141-7. PubMed ID: 9239168
[TBL] [Abstract][Full Text] [Related]
36. Nausea and vomiting with high-dose chemotherapy and stem cell rescue therapy: a review of antiemetic regimens.
Trigg ME; Inverso DM
Bone Marrow Transplant; 2008 Oct; 42(8):501-6. PubMed ID: 18724391
[TBL] [Abstract][Full Text] [Related]
37. The cardiovascular safety of high-dose intravenous granisetron in cancer patients receiving highly emetogenic chemotherapy.
Carmichael J; Harris AL
Cancer Chemother Pharmacol; 2004 Feb; 53(2):123-8. PubMed ID: 14634790
[TBL] [Abstract][Full Text] [Related]
38. [Nausea and vomiting].
Fujii M
Nihon Rinsho; 2003 Jun; 61(6):954-8. PubMed ID: 12806942
[TBL] [Abstract][Full Text] [Related]
39. Granisetron in the control of radiotherapy-induced nausea and vomiting: a comparison with other antiemetic therapies.
Feyer P; Seegenschmiedt MH; Steingraeber M
Support Care Cancer; 2005 Sep; 13(9):671-8. PubMed ID: 16044252
[TBL] [Abstract][Full Text] [Related]
40. [Efficacy of granisetron as anti-emetic agent for emesis induced by intra-arterial injection therapy for hepatocellular carcinoma].
Ichida T; Isokawa O; Itoh S; Ohta H; Takagi K; Hatakeyama S; Tsuruya T; Doya Y; Nozawa A; Hata K; Hara H; Hirose S; Watanabe T; Asakura H
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1939-46. PubMed ID: 9797817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
